Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05538533 · ClinicalTrials.gov registry record · NA

Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)

A NA study of Head and Neck Cancer, sponsored by Medical College of Wisconsin.

Active
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT05538533 is a NA study of Head and Neck Cancer that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 12 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05538533, a NA study of Head and Neck Cancer, is active but no longer recruiting, sponsored by Medical College of Wisconsin.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This is a phase 1 study to determine the safety of a condensed preoperative radiation regimen (10, 7, or 5 fractions) for the management of head and neck squamous cell carcinoma.

Conditions Studied

Interventions

  • RADIATION 46 Gy Radiation Therapy
  • RADIATION 40 Gy Radiation Therapy
  • RADIATION 35 Gy Radiation Therapy

Study Locations (1)

Wisconsin

  • Froedtert Hospital and the Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2023-01-06
Est. Completion 2026-08
Phase NA

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT05538533

The ClinicalTrials.gov registry entry for NCT05538533 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 3 interventions - of which 46 Gy Radiation Therapy is the first listed.

NCT05538533 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05538533 about?

NCT05538533 is a clinical study titled "Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)". This is a phase 1 study to determine the safety of a condensed preoperative radiation regimen (10, 7, or 5 fractions) for the management of head and neck squamous cell carcinoma.

What is the current status of trial NCT05538533?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2023-01-06. Estimated completion is 2026-08.

What conditions does trial NCT05538533 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT05538533?

The interventions under investigation include: 46 Gy Radiation Therapy (RADIATION), 40 Gy Radiation Therapy (RADIATION), 35 Gy Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT05538533?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05538533 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.